In the near future, clinical trials will use machine learning routinely to analyze data. Today, however, machine learning is still at an adoption midpoint—no longer pioneering, but not yet ubiquitous.
Solution Supports Analysis of Multiparametric data with Machine-Learning-Based Advanced Analysis to Identify Rare Cellular Populations TOKYO, Nov. 17, 2022 /PRNewswire/ -- Sony Corporation ("Sony") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results